financetom
Business
financetom
/
Business
/
Emera's Price Target Raised to $49 from $48 by National Bank of Canada
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Emera's Price Target Raised to $49 from $48 by National Bank of Canada
Aug 6, 2024 6:06 AM

08:36 AM EDT, 08/06/2024 (MT Newswires) -- Emera's ( EMRAF ) price target increased to $49 from $48 while its Sector Perform rating remained unchanged due to the company's improved balance sheet, National Bank of Canada said in a Tuesday note.

The bank made the price target change after Emera ( EMRAF ) agreed to sell its New Mexico Gas business to Bernhard Capital Partners for US$$1.252 billion.

With the deal, National Bank said Emera ( EMRAF ) surpassed the 15% asset sale portion of tis three-year capital plan.

Emera's ( EMRAF ) share price rose 1.6% on Friday to $49.71.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Jet.AI Q3 revenue falls 56%, operating loss narrows
Jet.AI Q3 revenue falls 56%, operating loss narrows
Nov 14, 2025
Overview * Jet.AI ( JTAI ) Q3 revenue declines to $1.7 mln from $3.9 mln last year * Company reports operating loss of $2 mln, an improvement from $2.9 mln last year * Jet.AI ( JTAI ) progresses on Canadian Hyperscale Data Center Project, completing second milestone Outlook * Jet.AI ( JTAI ) prioritizes completing third milestone of Canadian data...
Bioelectronic medicine maker Tivic Health's Q3 net loss widens
Bioelectronic medicine maker Tivic Health's Q3 net loss widens
Nov 14, 2025
Overview * Tivic Health ( TIVC ) Q3 revenue rises to $146,000, final quarter for direct ClearUP sales * Net loss widens to $2.6 mln in Q3, impacted by consumer business wind down Outlook * Company did not provide specific financial guidance for future quarters or years Result Drivers * MILITARY INTEREST - Tivic advanced discussions on deploying Entolimod as...
Wellness services firm XWELL's Q3 operating loss narrows
Wellness services firm XWELL's Q3 operating loss narrows
Nov 14, 2025
Overview * XWELL Q3 2025 revenue totals $7.3 mln, with cost of sales decreasing 8% yr/yr * Operating loss for Q3 2025 narrows to $0.8 mln from $4.8 mln yr/yr * XWELL ( XWEL ) expands Priority Pass partnership to Middle East and Europe Outlook * Company expands Priority Pass partnership to international airports in Middle East and Europe *...
Specialty cancer diagnostics firm Precipio Q3 revenue rises 30% driven by new customers 
Specialty cancer diagnostics firm Precipio Q3 revenue rises 30% driven by new customers 
Nov 14, 2025
Overview * Precipio Q3 2025 revenue grows 30% YoY to $6.8 mln * Adjusted EBITDA turns positive in Q3 2025, improving by over $500K from Q2 * Company generates $285K cash from operations in Q3 2025 Outlook * Company anticipates gross margins to increase towards 50% Result Drivers * PATHOLOGY SERVICES GROWTH - Revenue increased 20% due to new customer...
Copyright 2023-2026 - www.financetom.com All Rights Reserved